Halkidis相关文献与解析，生知库 | 链接生命科学的每一步

McCullagh, Martin; Zeczycki, Tonya N; Kariyawasam, Chathuri S; Durie, Clarissa L; Halkidis, Konstantine; Fitzkee, Nicholas C; Holt, Jo M; Fenton, Aron W

发表日期：2024

文献求助收藏

Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura.

免疫性血栓性血小板减少性紫癜中多抗体与ADAMTS13结合的机制研究

期刊:Research and Practice in Thrombosis and Haemostasis

影响因子:3.4

doi:10.1016/j.rpth.2024.102603

Halkidis Konstantine, Meng Chan, Pillai Vikram G, Shay Madison, Liu Szumam, Zheng X Long

其它

发表日期：2024

文献求助收藏

The history of thrombotic thrombocytopenic purpura research: a narrative review

血栓性血小板减少性紫癜研究史：叙述性综述

期刊:

影响因子:

doi:10.21037/aob-23-46

Halkidis, Konstantine; Lämmle, Bernhard; Zheng, X Long

Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura

免疫性血栓性血小板减少性紫癜中人单克隆抗体抑制机制

期刊:Blood

影响因子:21

doi:10.1182/blood.2022019252

Konstantine Halkidis, Chan Meng, Szumam Liu, Leland Mayne, Don L Siegel, X Long Zheng

ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura

ADAMTS13构象及其在免疫性血栓性血小板减少性紫癜中的抑制机制

期刊:Journal of Thrombosis and Haemostasis

影响因子:5

doi:10.1111/jth.15822

Halkidis, Konstantine; Zheng, X Long

Exome Sequencing Identifies Abnormalities in Glycosylation and ANKRD36C in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

外显子组测序鉴定出免疫介导性血栓性血小板减少性紫癜患者的糖基化和 ANKRD36C 异常

期刊:Thrombosis and Haemostasis

影响因子:5

doi:10.1055/s-0040-1719030

Malay Kumar Basu, Felipe Massicano, Lijia Yu, Konstantine Halkidis, Vikram Pillai, Wenjing Cao, Liang Zheng, X Long Zheng

A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura

针对ADAMTS-13远端羧基末端的人类单克隆抗体可调节其对血栓性血小板减少性紫癜抑制剂的敏感性

期刊:Journal of Thrombosis and Haemostasis

影响因子:5

doi:10.1111/jth.15332

Halkidis, Konstantine; Siegel, Don L; Zheng, X Long

Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.

血浆中 S100A8/A9、组蛋白/DNA 复合物和游离 DNA 的水平可预测免疫性血栓性血小板减少性紫癜的不良后果

期刊:Journal of Thrombosis and Haemostasis

影响因子:5

doi:10.1111/jth.15176

Sui Jingrui, Lu Ruinan, Halkidis Konstantine, Kocher Nicole K, Cao Wenjing, Marques Marisa B, Zheng X Long

其它

发表日期：2021

文献求助收藏

Editorial: Antibody-mediated thrombotic disease

社论：抗体介导的血栓性疾病

The modern role of corticosteroids in immune thrombotic thrombocytopenic purpura

皮质类固醇在免疫性血栓性血小板减少性紫癜中的现代作用

What is allosteric regulation? Exploring the exceptions that prove the rule!

什么是变构调节？探索那些证明规则的例外情况！

Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura.

免疫性血栓性血小板减少性紫癜中多抗体与ADAMTS13结合的机制研究

The history of thrombotic thrombocytopenic purpura research: a narrative review

血栓性血小板减少性紫癜研究史：叙述性综述

Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura

免疫性血栓性血小板减少性紫癜中人单克隆抗体抑制机制

ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura

ADAMTS13构象及其在免疫性血栓性血小板减少性紫癜中的抑制机制

Exome Sequencing Identifies Abnormalities in Glycosylation and ANKRD36C in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

外显子组测序鉴定出免疫介导性血栓性血小板减少性紫癜患者的糖基化和 ANKRD36C 异常

A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura

针对ADAMTS-13远端羧基末端的人类单克隆抗体可调节其对血栓性血小板减少性紫癜抑制剂的敏感性

Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.

血浆中 S100A8/A9、组蛋白/DNA 复合物和游离 DNA 的水平可预测免疫性血栓性血小板减少性紫癜的不良后果